| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Interleukin-6|IL-6|B-cell stimulatory factor 2|BSF-2|CTL differentiation factor|CDF|Hybridoma growth factor|Interferon beta-2|IFN-beta-2|IL6|IFNB2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse IL-6 (Interleukin 6) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Cytokines are secreted signaling proteins that coordinate immune responses and inflammation through receptor-mediated pathways.
Biological role and mechanism
The biological role of IL-6 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of IL-6 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
IL-6 (Interleukin 6) may also be referenced as Interleukin-6, IL-6, and B-cell stimulatory factor 2 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how IL-6 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in IL-6 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
IL-6 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Hybrid Exosome–Liposome Nanoparticles for Dual Modulation of Neuroinflammation and Lipid Metabolism in Ischemic Stroke
IF: 16 Journal: ACS Nano Author: Department of Pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi 530021, China. Cited Date: 2025-10-17
Velcro-Inspired Poly (ethylene glycol) Gel (PEGgel) for Robust Interface Adhesion Between Hydrogel, Device, and Tissue
IF: 16 Journal: ACS Nano Author: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, PR China. Cited Date: 2025-10-17
Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics
IF: 15.1 Journal: Advanced Science Author: Gaozhou People's Hospital, Maoming, 525200, China. Cited Date: 2024-03-29
Dynamic Profiling of Penicillin‐Binding Protein 2a (PBP2a)‐Positive Extracellular Vesicles: Implications for Early Diagnosis and Treatment Monitoring of Methicillin‐Resistant Staphylococcus Aureus Infections
IF: 14.5 Journal: Journal of Extracellular Vesicles Author: Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Cited Date: 2025-07-25
Elevated Apolipoprotein E Expression in Hippocampal Microglia Drives Temporal Lobe Epilepsy Progression
IF: 14.1 Journal: Advanced Science Author: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Road, Beijing, 100053, China. Cited Date: 2025-10-24
Flos Puerariae-derived exosomes-like nanoparticles ameliorate alcoholic liver disease by targeting IL-11-related signaling pathways and reactive oxygen species
IF: 13.4 Journal: Chemical Engineering Journal Author: School of Pharmacy, Shenyang Pharmaceutical University, No.103 Wenhua Road, Shenhe District, Shenyang 110016, China Cited Date: 2025-03-28
Carbon dots-mediated lysosomal iron sequestration for cancer immunostimulation
IF: 13.2 Journal: Chemical Engineering Journal Author: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, State Key Laboratory of Oncology in South China, Sun Yat-Sen University, Guangzhou 510275, PR China Cited Date: 2025-09-19
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes
IF: 12.8 Journal: Journal of Autoimmunity Author: Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain; Neuromuscular Diseases Group, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. Cited Date: 2024-03-15